Literature DB >> 33684277

A Patient with neonatal cholestasis.

Kristl G Claeys1,2, Luc Breysem3, Eric Legius4,5, Hilde Brems4,5, David Cassiman6, Matthieu Moisse7,8, Pieter Vermeersch9,10, Elena Levtchenko11,12, Jaak Jaeken10.   

Abstract

The patient, a boy born in 1991, showed pronounced polyostotic fibrous dysplasia due to McCune-Albright syndrome, as well as Gilbert syndrome and Charcot-Marie-Tooth neuropathy caused by a DNM2 mutation. In addition, the patient, his sister, mother and maternal grandfather had intermittently increased plasma arginine and lysine levels, most probably due to heterozygosity for a novel pathogenic SLC7A2 variant.
© 2021 Kristl G. Claeys et al. published by Sciendo.

Entities:  

Keywords:  CAT-2; Gilbert syndrome; dynamin-2 deficiency; polyostotic fibrous dysplasia

Mesh:

Year:  2021        PMID: 33684277      PMCID: PMC8330358          DOI: 10.34763/jmotherandchild.20202404.d-20-00012

Source DB:  PubMed          Journal:  J Mother Child        ISSN: 1428-345X


Patient report

The patient, a Belgian boy, was born in 1991 after an uncomplicated 43-week pregnancy. The parents are not related. He has two healthy sisters (see Fig 1 for the family tree). His birth weight was 3,870 g, and length was 55 cm. He was admitted at 9 weeks for fluctuating jaundice since birth. Clinical examination also showed a relative microcephaly (39.7 cm [50th centile]) for a length of 62 cm (97th centile), moderate hepatosplenomegaly and dark urine. Hyperbilirubinaemia was present (13.6 mg/dL), mostly of the conjugated type (10.3 mg/dL). Liver puncture biopsy was carried out to investigate the aetiology of this cholestasis; there was hypoplasia of the internal bile ducts. Peroperative cholangiography revealed normal external bile ducts. The cholestasis progressively normalised, but since its aetiology remained unclear, a control liver puncture biopsy was performed at 1 year to evaluate possible residual damage. This showed normal bile ducts. On further follow-up, there was mild, intermittent jaundice due to genetically proven Gilbert syndrome (homozygosity for seven TA repeats in the TATA box of the promoter of the UGT1A1 gene, as is typically associated with Gilbert syndrome: A(TA)7TAA/A(TA)7TAA). The cause of his transient cholestasis remained unclear until, after a few years, café au lait spots appeared on his back, raising the possibility of a McCune– Albright syndrome.1 This was confirmed by finding the typical c.602G
Figure 1

Family tree of the patient with indication of the mutations.

Figure 2

(A, B) Anterior–posterior and lateral X-ray of the left elbow at 17 years of age. Multiple lytic lesions are found in the medullary location of the distal humerus with thick sclerotic septae towards the cortex and a well-defined lower border (best appreciated on the anterior–posterior incidence). There is no significant cortical thinning or cortical scalloping nor periosteal reaction. Periarticular soft tissue and fat pads appear normal, no signs of hydrops; (C, D, E) nuclear magnetic resonance imaging (MRI) of the left humerus (17 years of age) shows abnormal heterogeneous signal intensity of the medullary cavity of the humerus shaft, hyperintense compared to the intensity of the muscle on the short tau inversion recovery (STIR) and T1-weighted (T1W) sequences. The lesion extends from the proximal to the distal end, is non-enhancing and contains septations as well as a non-specific slightly enhanced nodular lesion in the lower half of the humeral shaft. The difference in the intensities between the lower and upper halves is due to more haemorrhagic and protein-rich fluid in the upper half. These findings are compatible with a non-progressive large cystic lesion in the left humerus shaft. If there is no genetic confirmation of polyostotic fibrous dysplasia, one could consider the possibility of a lymphangioma; (F,G) on follow-up MRI (at 25 years of age), the lesion has decreased in size with a residual component in the proximal humerus and bony ridges in the distal humerus.

Family tree of the patient with indication of the mutations. (A, B) Anterior–posterior and lateral X-ray of the left elbow at 17 years of age. Multiple lytic lesions are found in the medullary location of the distal humerus with thick sclerotic septae towards the cortex and a well-defined lower border (best appreciated on the anterior–posterior incidence). There is no significant cortical thinning or cortical scalloping nor periosteal reaction. Periarticular soft tissue and fat pads appear normal, no signs of hydrops; (C, D, E) nuclear magnetic resonance imaging (MRI) of the left humerus (17 years of age) shows abnormal heterogeneous signal intensity of the medullary cavity of the humerus shaft, hyperintense compared to the intensity of the muscle on the short tau inversion recovery (STIR) and T1-weighted (T1W) sequences. The lesion extends from the proximal to the distal end, is non-enhancing and contains septations as well as a non-specific slightly enhanced nodular lesion in the lower half of the humeral shaft. The difference in the intensities between the lower and upper halves is due to more haemorrhagic and protein-rich fluid in the upper half. These findings are compatible with a non-progressive large cystic lesion in the left humerus shaft. If there is no genetic confirmation of polyostotic fibrous dysplasia, one could consider the possibility of a lymphangioma; (F,G) on follow-up MRI (at 25 years of age), the lesion has decreased in size with a residual component in the proximal humerus and bony ridges in the distal humerus. In addition, the patient showed mild facial dysmorphism with a slight alternating intermittent strabismus, a prominent nose bridge and mouth, a thick lower lip and high-set ears. He successfully redid his first primary school year after 1.5-years of speech therapy, and from 12 years, he started vocational training without major problems. From the age of about 9 years, bilateral pes cavus, hammer toes and tendon hyporeflexia of the lower limbs were noted. Nerve conduction studies revealed a sensorimotor axonal and demyelinating polyneuropathy. Together with a moderate neutropenia, this suggested dynamin 2 deficiency, confirmed by finding a known de novo pathogenic variant in DNM2 (NM_001005360.2; c.1684_1686del; p.Lys562del).3 He did not have cataracts. Finally, the patient, his sister, mother and maternal grandfather showed moderate, fluctuating increases of plasma arginine (up to 200 μM; normal range: 10–130 μM) and lysine (up to 408 μM; normal range: 50–280 μM). Whole-exome sequencing showed a novel variant in SLC7A2 (NM_001164771.2; c.1202C Actually, at the age of 29 years, the patient has a mild/ moderate ataxic gait due to his polyneuropathy with bilateral pes cavus, hammer toes and hyporeflexia of the lower limbs. In addition, he shows an alternating convergent strabismus. Otherwise, he is functioning within normal limits.
  4 in total

1.  Infant cholestasis in McCune-Albright syndrome.

Authors:  N El-Rifai; S Lumbroso; M Cartigny; J Weill; C Sultan; F Gottrand
Journal:  Acta Paediatr       Date:  2004-01       Impact factor: 2.299

2.  A new metabolic disorder in human cationic amino acid transporter-2 that mimics arginase 1 deficiency in newborn screening.

Authors:  Raquel Yahyaoui; Javier Blasco-Alonso; Carmen Benito; Enrique Rodríguez-García; Fernando Andrade; Luis Aldámiz-Echevarría; María C Muñoz-Hernández; Ana I Vega; Celia Pérez-Cerdá; María L García-Martín; Belén Pérez
Journal:  J Inherit Metab Dis       Date:  2019-02-21       Impact factor: 4.982

3.  Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy.

Authors:  Kristl G Claeys; Stephan Züchner; Marina Kennerson; José Berciano; Antonio Garcia; Kristien Verhoeven; Elsdon Storey; John R Merory; Henriette M E Bienfait; Martin Lammens; Eva Nelis; Jonathan Baets; Els De Vriendt; Zwi N Berneman; Ilse De Veuster; Jefferey M Vance; Garth Nicholson; Vincent Timmerman; Peter De Jonghe
Journal:  Brain       Date:  2009-06-05       Impact factor: 13.501

Review 4.  Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium.

Authors:  Muhammad Kassim Javaid; Alison Boyce; Natasha Appelman-Dijkstra; Juling Ong; Patrizia Defabianis; Amaka Offiah; Paul Arundel; Nick Shaw; Valter Dal Pos; Ann Underhil; Deanna Portero; Lisa Heral; Anne-Marie Heegaard; Laura Masi; Fergal Monsell; Robert Stanton; Pieter Durk Sander Dijkstra; Maria Luisa Brandi; Roland Chapurlat; Neveen Agnes Therese Hamdy; Michael Terrence Collins
Journal:  Orphanet J Rare Dis       Date:  2019-06-13       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.